SGT1 Antibody

What is SGT1 and why is it important in research?

SGT1 is a highly conserved eukaryotic protein originally identified in yeast as a ubiquitin ligase-associated protein that interacts with SKP1, a component of the SCF (Skp1/Cdc53/F-box protein) ubiquitin ligase complex . SGT1 has emerged as a critical component in multiple biological processes:

• In plants: Essential for disease resistance mediated by nucleotide-binding site/leucine-rich repeat (NBS-LRR) proteins

• In yeast: Required for kinetochore assembly

• In humans: Functions in kinetochore assembly and immune signaling through Nod1 activation

SGT1 contains three conserved domains - TPR, CS, and SGS - each mediating specific protein-protein interactions that facilitate SGT1's diverse functions .

How should I select an appropriate SGT1 antibody for my experiment?

When selecting an SGT1 antibody, consider:

• Target species specificity: Ensure the antibody recognizes your species of interest. SGT1 is highly conserved but has species-specific variations .

• Domain recognition: Determine which SGT1 domain needs to be detected. Some antibodies target specific domains (TPR, CS, or SGS) .

• Application compatibility: Verify the antibody is validated for your intended application (WB, IP, IHC, etc.) .

• Validation evidence: Check if the antibody has been validated with proper controls including knockout/knockdown samples .

For plant studies, antibodies raised against Arabidopsis SGT1 can cross-react with other plant species like Nicotiana benthamiana due to conservation .

Which experimental controls should I include when using SGT1 antibodies?

Rigorous controls are essential for reliable SGT1 antibody experiments:

• Positive control: Include lysates from tissues/cells known to express SGT1 (most tissues express SGT1 as it's essential) .

• Negative control: Use SGT1-silenced or knockout samples where available .

• Loading control: Include antibodies against housekeeping proteins (tubulin, actin) to normalize expression levels .

• Specificity control: For immunoprecipitation experiments, include non-specific IgG controls .

• Peptide competition: Pre-incubate the antibody with the immunizing peptide to confirm specificity .

A crucial validation shown in the literature is comparing SGT1 antibody detection in control vs. VIGS-silenced plants (for plant studies) or siRNA-depleted mammalian cells .

How can I simultaneously study multiple SGT1 isoforms?

Many organisms express multiple SGT1 isoforms with potentially redundant or specialized functions. For example, Arabidopsis contains two isoforms (AtSGT1a and AtSGT1b) that are 87% similar at the amino acid level .

Methodological approach:

• Isoform-specific antibodies: Design antibodies against divergent regions between isoforms. The variable regions between TPR and CS domains often differ between isoforms .

• Compensatory expression analysis: When one isoform is absent, the other may be upregulated. This table summarizes a methodological approach:

• Expression pattern analysis: Use RT-qPCR in parallel with western blotting to correlate transcript levels with protein detection .

• Knockout verification: The double mutant of AtSGT1a and AtSGT1b is embryo-lethal in Arabidopsis, providing a functional validation of antibody specificity .

How can I properly interpret contradictory SGT1 antibody results between different experimental approaches?

Researchers often encounter contradictory results when studying SGT1 using different approaches. These discrepancies may result from:

• Post-translational modifications: SGT1 can be phosphorylated, affecting antibody recognition .

• Protein complexes: Association with HSP90 or RAR1 may mask epitopes .

• Cell/tissue-specific expression patterns: Expression levels vary between tissues .

Methodological resolution approaches:

• Combined techniques: Validate findings using multiple techniques (western blot, immunofluorescence, mass spectrometry).

• Epitope mapping: Determine which domain/region your antibody recognizes and assess if this region might be occluded in certain contexts.

• Denaturation conditions: Compare results under native vs. denaturing conditions.

• Cross-validation: Use multiple antibodies targeting different SGT1 epitopes .

How can I effectively use SGT1 antibodies to study protein-protein interactions in immune signaling pathways?

SGT1 functions within multiprotein complexes involving HSP90, RAR1, and various R proteins in plants or Nod proteins in mammals .

Advanced methodological approaches:

• Co-immunoprecipitation optimization:

  • Use mild detergents (0.5% NP-40) to preserve protein-protein interactions

  • Cross-link antibodies to Sepharose using methods like the Seize Primary Immunoprecipitation kit

  • Include both native and denatured samples to distinguish direct vs. indirect interactions

• Sequential immunoprecipitation:

  • First IP: Anti-SGT1 antibody

  • Elution under mild conditions

  • Second IP: Antibody against interacting protein (HSP90, RAR1, etc.)

  • This confirms the presence of complexes containing both proteins

• Domain-specific antibodies:

  • Utilize antibodies targeting specific SGT1 domains to identify which regions mediate specific interactions

  • The CS domain interacts with HSP90 and RAR1's CHORD domains

Why might SGT1 antibodies show inconsistent results in Western blot applications?

Inconsistent Western blot results with SGT1 antibodies can stem from several factors:

• Protein degradation: SGT1 stability is regulated; some isoforms (like AtSGT1a) are less stable than others (AtSGT1b) .

• Sample preparation: Harsh extraction conditions may disrupt epitopes.

• Antibody quality: Batch-to-batch variation may occur with polyclonal antibodies .

• Cross-reactivity: Some antibodies may detect both isoforms or related proteins.

Methodological solutions:

• Optimization of extraction buffer:

  • Include protease inhibitors

  • Use buffer A (50 mM Tris-HCl [pH 7.5], 0.5% NP-40, 150 mM NaCl, 10 mM β-glycerophosphate, protease inhibitor cocktail)

• Fresh sample preparation: SGT1 in plant tissues shows degradation with storage .

• Control for phosphorylation state: Treatment with phosphatase may affect antibody recognition.

• Gel percentage optimization: SGT1 (~40 kDa) resolves optimally on 10-12% SDS-PAGE gels.

How can I optimize flow cytometry experiments using SGT1 antibodies?

Flow cytometry with SGT1 antibodies requires special consideration as SGT1 is primarily intracellular:

• Permeabilization optimization:

  • Test different permeabilization agents (0.1% Triton X-100, 70% ethanol, commercial kits)

  • Optimize time and temperature for permeabilization

• Voltage/gain settings:

  • Ensure all data falls within detectable range

  • Once data is recorded, voltages/gains cannot be altered; samples must be re-recorded if settings are incorrect

• Compensation and time parameter checks:

  • Before analysis, check for compensation and inconsistencies in time parameter

  • Incorrect compensation can be fixed by generating a new compensation matrix

• Antibody titration:

  • Determine optimal antibody concentration using a titration series

  • Plot signal-to-noise ratio against antibody concentration to identify optimal dilution

What are potential pitfalls when using SGT1 antibodies in Agrobacterium-mediated transient expression systems?

Agrobacterium-mediated transient expression in SGT1-silenced plants presents specific challenges:

Problem identification: SGT1-silenced N. benthamiana plants show poor accumulation of heterologously expressed proteins compared to control plants .

Methodological solutions:

• Timing optimization: Perform experiments earlier after VIGS initiation (before complete SGT1 depletion) .

• Control selection: Use proper controls (TRV empty vector-infected plants) rather than wild-type plants .

• Protein stability verification: Always include Western blot analysis to confirm expression levels of transiently expressed proteins.

• Alternative delivery methods: Consider direct protein delivery methods if transient expression is compromised.

How can SGT1 antibodies be used to study the structural dynamics of SGT1-containing complexes?

SGT1 forms dynamic complexes with HSP90, RAR1, and immune receptors. Advanced structural biology approaches can be enhanced with SGT1 antibodies:

• Proximity-based assays:

  • Use epitope-specific antibodies for proximity ligation assays

  • Combine with site-directed mutagenesis of key residues like Tyr157 and Lys221 in the CS domain that are critical for HSP90 interaction

• Conformational antibodies:

  • Develop antibodies that recognize specific conformational states of SGT1

  • Use to distinguish active vs. inactive complex states

• Domain-specific analysis:

  • The CS domain is critical for HSP90 binding

  • The SGS domain is essential for immune function

  • Domain-specific antibodies can track individual domain functions

• In situ structural analysis:

  • Combine with advanced imaging techniques (FRET, FLIM)

  • Use domain-specific antibodies labeled with compatible fluorophores

What methodologies can detect SGT1 post-translational modifications using specific antibodies?

SGT1 function is regulated by post-translational modifications, which can be studied using specialized approaches:

• Phosphorylation-specific antibodies:

  • Develop antibodies against known phosphorylation sites

  • Validate with phosphatase treatment controls

• 2D gel electrophoresis:

  • Separate SGT1 based on both isoelectric point and molecular weight

  • Use SGT1 antibodies to detect phosphorylated species

• Ubiquitination analysis:

  • SGT1 associates with ubiquitin ligase complexes and may itself be ubiquitinated

  • Immunoprecipitate with SGT1 antibodies followed by ubiquitin detection

• Mass spectrometry validation:

  • Confirm antibody-detected modifications by mass spectrometry

  • Immunoprecipitate SGT1 using validated antibodies, followed by MS analysis

How can I differentiate between direct and indirect SGT1 interactions in multiprotein complexes?

SGT1 functions within complex networks involving HSP90, RAR1, and various immune receptors. Distinguishing direct from indirect interactions requires sophisticated approaches:

• Cross-linking immunoprecipitation:

  • Use membrane-permeable crosslinkers at optimized concentrations

  • Perform sequential immunoprecipitation with SGT1 antibodies followed by antibodies against potential interactors

  • Analyze by mass spectrometry to identify directly crosslinked partners

• In vitro binding assays with purified components:

  • Express and purify SGT1 domains (TPR, CS, SGS)

  • Perform direct binding assays with purified interacting proteins

  • Use antibodies to detect formation of specific complexes

• Competition assays:

  • The CS domain and CHORD I compete for binding to HSP90-NTD

  • HSP90-NTD and CHORD II can bind simultaneously to the CS domain

  • Use domain-specific antibodies to track these interactions

How can SGT1 antibodies be applied to study the role of SGT1 in non-canonical pathways?

Beyond established roles in immunity and kinetochore assembly, SGT1 functions in other cellular processes that can be explored using antibodies:

• Developmental regulation:

  • The Arabidopsis sgt1a-1 sgt1b-1 double mutant is embryo lethal

  • Use SGT1 antibodies to track expression patterns during development

  • Combine with tissue-specific markers to identify developmental roles

• Auxin signaling:

  • Mutations in AtSGT1b (eta3) were identified as genetic enhancers of the tir1-1 mutation with impaired auxin responses

  • SGT1 antibodies can help characterize SGT1's role in SCF TIR1 complex formation

• Stress responses beyond immunity:

  • Track SGT1 localization and protein level changes under various abiotic stresses

  • Combine with phosphoproteomic analysis to identify stress-specific modifications

What considerations are important when using SGT1 antibodies to study evolutionary conservation of immune mechanisms?

SGT1's remarkable conservation across kingdoms makes it valuable for comparative studies:

• Cross-species reactivity testing:

  • Test antibodies raised against one species SGT1 for cross-reactivity with orthologs

  • Optimize conditions for each species due to sequence variations

• Functional domain conservation:

  • Use domain-specific antibodies to compare the conservation of specific domains

  • The CS domain shows high conservation and interacts with HSP90 across kingdoms

• Co-evolution analysis:

  • Compare SGT1-interacting partners across species using co-immunoprecipitation

  • Determine if SGT1-dependent pathways show similar organization across kingdoms

How can SGT1 antibodies be integrated with advanced imaging techniques to study dynamic protein interactions?

Combining SGT1 antibodies with cutting-edge imaging approaches offers new insights:

• Super-resolution microscopy:

  • Use highly specific SGT1 antibodies with appropriate fluorophores

  • Optimize sample preparation to minimize background and maximize resolution

  • Track SGT1 localization during immune responses with nanometer precision

• Live-cell imaging approaches:

  • For fixed cells, use SGT1 antibodies to validate GFP-tagged SGT1 constructs

  • Ensure tagged constructs maintain functional interactions verified by antibody-based methods

• Single-molecule tracking:

  • Validate antibody fragments (Fab) for single-molecule studies

  • Track dynamics of SGT1-containing complexes during immune activation